Abstract

62. Modulating Transgenic Factor IX to Therapeutic Levels Following Low-Dose Administration of AAV in Fah-Deficient Mice

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call